NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Kwality Pharmaceuticals has upwardly revised its FY27 revenue guidance to over ₹700 crore, reflecting a 40 percent year-on-year growth target. The company is strategically positioning itself to double its revenue to ₹1,500 crore by FY30, driven by aggressive international registrations and the commissioning of new manufacturing facilities.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
